Vise Technologies Inc. raised its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 73.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,159 shares of the financial services provider's stock after purchasing an additional 2,182 shares during the quarter. Vise Technologies Inc.'s holdings in CME Group were worth $1,198,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Simon Quick Advisors LLC grew its stake in shares of CME Group by 28.5% during the fourth quarter. Simon Quick Advisors LLC now owns 1,523 shares of the financial services provider's stock valued at $354,000 after purchasing an additional 338 shares during the last quarter. Janney Montgomery Scott LLC lifted its holdings in CME Group by 15.0% during the 4th quarter. Janney Montgomery Scott LLC now owns 55,758 shares of the financial services provider's stock worth $12,949,000 after buying an additional 7,285 shares in the last quarter. Mutual Advisors LLC boosted its position in CME Group by 4.4% in the 4th quarter. Mutual Advisors LLC now owns 2,115 shares of the financial services provider's stock valued at $491,000 after buying an additional 90 shares during the last quarter. Avior Wealth Management LLC increased its stake in shares of CME Group by 51.6% in the 4th quarter. Avior Wealth Management LLC now owns 329 shares of the financial services provider's stock valued at $76,000 after buying an additional 112 shares during the period. Finally, MFA Wealth Services acquired a new stake in shares of CME Group in the 4th quarter valued at $220,000. Institutional investors and hedge funds own 87.75% of the company's stock.
Insider Buying and Selling
In other CME Group news, insider Derek Sammann sold 4,650 shares of the business's stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the sale, the insider now directly owns 8,336 shares of the company's stock, valued at $2,339,164.96. The trade was a 35.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, COO Suzanne Sprague sold 1,500 shares of the stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the transaction, the chief operating officer now owns 8,036 shares of the company's stock, valued at approximately $2,063,885.88. This represents a 15.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 24,400 shares of company stock valued at $6,533,180. Company insiders own 0.30% of the company's stock.
CME Group Stock Down 0.1%
Shares of NASDAQ:CME traded down $0.35 during trading on Thursday, hitting $285.63. 462,999 shares of the company's stock traded hands, compared to its average volume of 2,180,980. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a 50-day moving average price of $269.01 and a 200-day moving average price of $250.25. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $287.05. The company has a market cap of $102.93 billion, a price-to-earnings ratio of 29.51, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45.
CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The firm had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the firm posted $2.50 earnings per share. The business's revenue was up 10.4% on a year-over-year basis. As a group, research analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.75%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's payout ratio is presently 50.30%.
Analyst Upgrades and Downgrades
CME has been the topic of several research reports. UBS Group upped their price target on CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a research note on Friday, April 25th. JPMorgan Chase & Co. dropped their price target on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research note on Thursday, April 24th. Piper Sandler raised their price objective on shares of CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a research note on Tuesday, April 8th. Erste Group Bank lowered shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, Morgan Stanley increased their price target on CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a research note on Thursday, April 24th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $256.80.
Check Out Our Latest Stock Report on CME
CME Group Company Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.